1. Intratumoral injection of anhydrous alcohol under ultrasound guided percutaneous transhepatic tumor implantation in the treatment of liver cancer anhydrous alcohol. In less than 3 cm diameter tumor, the number of nodules were within three with cirrhosis of liver cancer surgery and not the top. A pair of small hepatocellular carcinoma may be cured. ≥ 5 cm poor results.

     2. Application-oriented treatment and the monoclonal antibody specific antibody or pro-tumor drug for the chemical carrier, marking radionuclide or with chemotherapy drugs or immunotoxins crosslinking specific guidance for the treatment, there is hope for one of the therapy. Clinical use of the antibody has a protein antibody against human liver cancer, liver cancer monoclonal anti-human antibody, monoclonal antibodies, anti-AFP. “Warheads” has been tried, except 131I125I 90Y, in addition toxic protein and antibody with the chemotherapy drug crosslinked human monoclonal antibodies or genetic engineering, is being examined.